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View Article OnlineWater-soluble bis(1,10-phenanthroline) octanedioate Cu2+ and Mn2+
complexes with unprecedented nano and picomolar in vitro cytotoxicity:
promising leads for chemotherapeutic drug development†
Andrew Kellett,‡*a Mark O’Connor,a Malachy McCann,b Orla Howe,a Alan Casey,a Pauraic McCarron,ab
Kevin Kavanagh,c Mary McNamara,a Sean Kennedy,a Donald D. May,d Philip S. Skell,e Denis O’Sheaa
and Michael Devereux*a
Received 19th December 2010, Accepted 8th March 2011
DOI: 10.1039/c0md00266fDinuclear Cu2+ and Mn2+ bis-phenanthroline octanedioate compounds exhibit rapid, unprecedented
nano and picomolar in vitro cytotoxicity against human-derived colorectal cancer lines (HT29, SW480
and SW620) and are less cytotoxic toward non-cancerous normal human keratinocyte cells (HaCaT).
Both complexes displayed greater in vivo drug tolerance compared to cisplatin when examined using the
insect Galleria mellonella. The compounds are potent generators of intracellular reactive oxygen species
within HT29 cells, display avid DNA binding and induce O2-dependent cleavage of supercoiled pUC18
DNA. The Cu2+ complex was found to display self-cleaving nuclease activity and a mechanism of
deoxyribose C–H bond activation is proposed, based on interactions with the superoxide anion and
hydrogen peroxide along with DNA cleavage observations under anaerobic conditions and with an
excess of the metal chelator EDTA.Introduction
The development of self-cleaving chemical nucleases is regarded
as the paradigm of redox active metal-based chemotherapeutics.
DNA targeting agents capable of inducing single stranded or
double stranded scission have found clinical application within
cancer chemotherapy.1 Other applications within this class of
compound include, the probing of DNA-specific structures,
mapping of protein and DNA interactions, gene regulation and
signal transduction.2,3 Thus, explorations toward the discovery
and development of natural or synthetic chemical nucleases are
major topics of interest. Redox-active, transition-metal-based
chemical nucleases are particularly important due to theiraThe inorganic pharmaceutical and biomimetic research centre, Focas
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This journal is ª The Royal Society of Chemistry 2011potential to catalytically support the one-electron oxidation/
reduction reactions necessary to drive activation of C–H
deoxyribose bonds.
In the presence of Cu2+, the oxidative formation of p radical
cations within marine-based products, tambjamine E,4 prodi-
giosin5 and pyrimol,6 have recently been shown to mediate self-
cleaving DNA damage, i.e. scission which does not require the
presence of added oxidant or reductant. These Cu2+ compounds
have also demonstrated significant in vitro chemotherapeutic
potential against leukaemia and ovarian cancer cells, some of
which were resistant to cisplatin.5,6
The discovery of the first synthetic chemical nuclease, [Cu
(phen)2]
2+ (phen ¼ 1,10-phenanthroline, Fig. 1), has sparked
intensive effort toward the development of new bis(phen) agents
with enhanced DNA cleaving ability.7 The DNA cleaving limi-
tations of [Cu(phen)2]
2+ include, (i) a high dissociation constant
of the second coordinated phen ligand8 and (ii) the need for
exogenous reductant to generate the active Cu+ species, [Cu
(phen)2]
+. The dissociation problem was solved by Meunier, Pitie
et al.9–11 through the advent of clip-phen, whereby two phenFig. 1 Molecular strucutres of phen, odaH2 and the phthalates.
Med. Chem. Commun., 2011, 2, 579–584 | 579
Fig. 3 Molecular structures of the dimeric cation and anion subunits in
the MnII double salt complex {[Mn2(m2-oda)(phen)4(oda)2]
2[Mn2(m2-
oda)(phen)4(H2O)2]
2+} (2).
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View Article Onlineligands are connected at the 20 or 30 position by a serinol bridge.
Recently, we have reported the first self-cleaving bis-phen
system, [Cu(phen)2(phthalate)] (phthalate ¼ o-, m-, p-phthalate,
Fig. 1), capable of inducing single-stranded DNA scission in the
absence of exogenous reductant or oxidant.12
While mononuclear [Cu(phen)2(phthalate)] complexes dis-
played excellent chemotherapeutic potential against colon
(HT29), breast (MC-F7) and prostate (DU145) cancer lines, their
water solubility is poor. Of the phthalate group of Cu2+
complexes the cationic, dinuclear species [Cu2(phen)4(m2-p-
phthalate)]2+ proved to be the most active DNA-binding, self-
cleaving chemotherapeutic agent. To that end, in the current
study, we have investigated the application of water soluble Cu2+
and Mn2+ dinuclear, cationic, bis-phen octanedioate (oda)
(Fig. 1) systems as nuclease mimetics and determined their ability
to induce cancer cell death through the redox-generation of
reactive oxygen species (ROS). Arguments for the possible
formation of a p carboxyl radical within the Cu2+ system, which
cleaves DNA by self-activation, are also presented.
[Cu2(m2-oda)(phen)4](ClO4)2 (1) (Fig. 2), {[Mn2(m2-oda)(phe-
n)4(oda)2]
2[Mn2(m2-oda)(phen)4(H2O)2]
2+} (2) (Fig. 3), were
prepared according to the literature methods.13,14 The coordi-
nation environment about each of the Cu2+ ions in 1 is approx-
imately square-pyramidal with the metals being linked via
a bridging oda2 ligand. In the double complex salt, 2, the
environment about each Mn2+ is octahedral with both metals in
the cation and anion being bridged oda2 in a similar fashion to
1. Whereas each of the Mn2+ centres of the anionic subunit in 2
contain a unidentate oda2 ligand coordinated in the apical
position, the cationic unit contains bound water at these equiv-
alent positions.DNA binding studies
In order to examine the interaction of compounds 1 and 2 with
DNA, competitive ethidium bromide displacement and fluores-
cence quenching experiments with calf thymus DNA (CT-
DNAp) were conducted (Table 1).† Complexes 1 and 2 were
found to have high apparent DNA binding constants (Kapp), and
low fluorescence quenching values (Q), indicating that both
systems have a high affinity for binding to DNA. High Q values
(>20 mM) are generally found for ‘‘classical’’ DNA intercalants,
whereas lower values between 2–15 mMare typically obtained for
minor groove ligands or hybrid molecules.15,16Fig. 2 Molecular structure of the [Cu2(m2-oda)(phen)4]
2+ cation in
complex 1.
580 | Med. Chem. Commun., 2011, 2, 579–584DNA cleavage reactions
The relaxation of supercoiled pUC18 DNA (SC, Form I) into
open circular (OC, Form II) and linear (LC, Form III) confor-
mations was used to quantify the relative cleavage efficiency of 1
and 2.† To investigate the DNA self-cleaving ability of
complexes 1 and 2, SCDNAwas exposed to both complexes over
a concentration range of 1–50 mM for 20 h in the absence of
added H2O2 or reductant (Fig. 4(a)). Only complex 1 exhibits
concentration-dependant self-cleaving of SC DNA (Form I) to
OC (Form II), with complete depletion of the parent SC band (I
/ II) at 20 mM (lane 5 (a)). In the presence of added reductant
(ascorbate) (Fig. 4(b)) both complexes exhibit enhanced DNA
scission during a shorter time-frame (2 h) and at a lower
concentration of added complex. While both 1 and 2 induced
complete relaxation to OC Form II (lanes 4 and 8), only the Cu2+
complex, 1, was found to induce efficient double stranded scis-
sion (I/ III) at a concentration of 20 mM, which was evident by
the absence of a band in lane 5. In order to identify what role
molecular O2 and the metal ions (Cu
2+/Mn2+) play within DNA
cleavage, experiments were conducted under anaerobic condi-
tions in an atmosphere saturated with argon and, separately, in
the presence of 100 mM Na2EDTA, under aerobic conditionsTable 1 Apparent DNA binding constants (Kapp) and fluorescence
quenching (Q) values for 1 and 2.‡ Assay conditions; C50/Kapp: final
volume 2 mL, 1.2 mM EtBr, 1 mM CT-DNAp, 10 mM TES, 0.1 mM
Na2EDTA, pH 7.0; Q: final volume 2 mL, 2.0 mM EtBr, 20 mM CT-
DNAp, 2 mMNaOAc buffer, 9.3 mMNaCl, 0.1 mMNa2EDTA, pH 5.0
Complex C50
a (mM) Kapp
b Qc
1 46.89 2.55  105 22.64
2 28.46 4.20  105 43.13
a C50 ¼ concentration required to reduce fluorescence by 50%
(competitive). b Kapp ¼ Ke  1.26/C50 where Ke ¼ 9.5  106 M (bp)1.
c Q ¼ equivalent concentration required to reduce fluorescence by 50%
(quenching).
This journal is ª The Royal Society of Chemistry 2011
Fig. 4 Relaxation of pUC18 by 1 and 2.† Cleavage was carried out at 37
C then analyzed by agarose gel electrophoresis (a) 20 h incubation in the
absence of added oxidant or reductant. Lane 1: DNA alone; lanes 2–6: 1,
5, 10, 20, 50 mM 1; lanes 7–10: 5, 10, 20, 50 mM 2. (b) 2 h incubation in the
presence of added ascorbate (at twice the complex concentration). Lane
1: DNA alone; lanes 2–5: 1, 5, 10, 20 mM 1; lanes 6–9: 1, 5, 10, 20 mM 2. (c)
20 h incubation of 20 mM 1 in the absence of added oxidant or reductant.
Lane 1: 1 + 100 mM Na2EDTA; lane 2: sat. Ar atmosphere. (d) 2 h
incubation of 20 mM 2 with added ascorbate (at twice the complex
concentration). Lane 1: 2 + 100 mM Na2EDTA; lane 2: sat. Ar atmo-
sphere.
Table 2 Concentrations of complexes 1 and 2 equivalent to effect 1 U of
bovine erythrocyte SOD activity (50% Inhibition) and the catalase
mimetic potential of 1 and 2 examined as a function of H2O2 dispro-
portionation
Complex
Concentration
equivalent to 1 U bovine
SOD (mM)
Number of H2O2
molecules
disproportionated
by one molecule of
complex in the first 5 min14
1 1.300 0
2 0.024 6  103
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View Article Online(Fig. 4 (c) and (d)). The Mn2+ system was examined at
a concentration of 20 mM over a 2 h period in the presence of
ascorbate, while the Cu2+ system was tested over a longer time
period (20 h) and without added reductant. The Mn2+ complex,
2, did not cleave DNA in the absence of O2 and presence of
EDTA, however, complex 1 was found to induce some DNA
damage in the presence of excess metal chelator (EDTA) and
slight relaxation in the absence of O2.Table 3 LD50 (at95% CI) values for complexes 1 and 2, the free ligandRedox activity
Since the catalytic interaction of [Cu(phen)2]
2+ and its reduced
form, [Cu(phen)2]
+, with the superoxide radical (O2_
) and
hydrogen peroxide (H2O2) are imperative for cleaving the
phosphodiester backbone in DNA,17–19 we have examined the
interaction of complexes 1 and 2 with both these species.
Superoxide was generated enzymatically by the xanthine/
xanthine-oxidase system and quantified photometrically by the
detector molecule, nitro-blue-tetrazolium (NBT). Both 1 and 2
show potent SOD (superoxide dismutase) mimetic activity, with
theMn2+ complex being an exceptional catalyst (1 U SOD¼ 24.6
nM) (Fig. 5 and Table 2). The catalase (CAT) mimetic activity of
complexes 1 and 2 was determined by measuring the volume ofFig. 5 SOD activity profiles for complexes 1 and 2.
This journal is ª The Royal Society of Chemistry 2011evolved O2 from disproportionate H2O2 (30% v/v solution). Only
the Mn2+ complex (2) was capable of decomposing H2O2 and its
activity can also be described as exceptional in this regard (6 
103 H2O2 molecules disproportionated in 5 min). Overall, both 1
and 2 interacted with superoxide to produce hydrogen peroxide
(equation I), the Mn2+ complex being the most active. Further-
more, it was only the Mn2+ complex (2) which appeared capable
of disproportionating the peroxide molecules (equation II)
resulting from the superoxide conversion.
2O2_
 + 2H+/ 2H2O2 + O2 (SOD) (I)
2H2O2/ 2H2O + O2 (CAT) (II)Antitumour activity
The cytotoxicity of 1 and 2, the free phen ligand and the
clinical antitumour agent, cisplatin, were measured at 24 and 96
h intervals in triplicate using a standard MTT assay against
three progressive colorectal human-derived tumour cell lines
{HT29, SW480 (Dukes’ B) and SW620 (Dukes’ C)} along with
a non-cancerous normal human keratinocyte line (HaCaT).†
The average cytotoxicity data and the associated SD obtained
were then used to calculate LD50 values (95% CI) for each
cell line and time point (Table 3). Both complexes displayed
remarkable cytotoxicity against all three cancerous lines. LD50
activities in the low micromolar range were found for both
complexes after 24 h exposure and, significantly, these activities
reached the nano- and picomolar level after 96 h. As thephen and the antitumour agent cisplatin, against colorectal cancer lines
HT29, SW480 and SW620 along with non-cancerous human keratinocyte
line HaCaT. Experiments were conducted independently in triplicate over
a period of 24 and 96 h†
Antitumour Activity LD50 (mM)
HT29 SW480 SW620
HaCaT
24 h 96 h 24 h 96 h 24 h 96 h 96 h
phen >200 9.240 >200 10.70 160.00 10.700 5.500
1 9.610 <0.001 11.30 0.220 31.00 1.220 0.719
2 108.00 0.092 7.460 0.261 58.50 0.342 0.851
cisplatin 166.00 4.810 >200 1.290 >200 7.030 3.450
Med. Chem. Commun., 2011, 2, 579–584 | 581
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View Article Onlinecolorectal tumour lines progress (HT29/ SW480/ SW620)
the LD50 value for 1, over a 96 h period, fell from pico- to low
micromolar concentrations, while the activity of 2 remained
consistently in the low- to mid-nanomolar region. It is notable
that while cisplatin displays significant low-micromolar cyto-
toxicity against all tumour lines after 96 h, the activity of 1 and
2, in the same time period is much superior (by a factor
between approximately 1  101 – 5  103). Over a 96 h time
period, the LD50 values of cisplatin and phen against the
normal non-cancerous HaCaT cell line are approximately
equivalent to the values obtained against cancerous lines HT29,
SW480 and SW620. However, significant differences in the
HaCaT cell line, were found for complexes 1 and 2, particularly
when compared to the HT29 cell line. Compound 2 was found
to be 9.25 times less cytotoxic toward HaCaT cells when
compared to HT29, while, compound 1 was 700 times less
cytotoxic when compared to the HT29 cell line. One possible
way to explain the enhancement of toxicity towards cancer cells
in this study may relate to the activation of the oncogene, p53,
a vital tumour-suppressor gene that functions by inducing
apoptosis and preventing gene amplification and which is found
mutated in many forms of human cancer including HT29,
SW480 and SW620 carcinomas.20 It has already been demon-
strated that phen and its coordinated metal adducts enhance
the in vitro activity of p53 and can trigger apoptosis in p53
negative cell lines,21 however, it is not clear at present if this
oncogene plays any significant role in the toxicity profiles of
these phen reagents.Cellular reactive oxygen species study
In order to elucidate the relationship between cytotoxicity and
reactive oxygen species (ROS) generation, complexes 1 and 2,
along with metal-free phen and cisplatin, were exposed to HT29
colorectal cancer cells which had been pre-treated with the
intracellular ROS indicator 20,70-dichlorofluorescin diacetate
(DCFH-DA).† In the presence of endogenously generated ROS,
DCFH-DA is oxidised to release the fluorophore 20,70-dichlor-
ofluorescin (DFC). Results are shown as increases in cellular
ROS levels after drug exposure and are expressed in comparison
to the ROS level of unexposed controls (-Ctrl). A positive control
of 0.5 mM hydrogen peroxide (+Ctrl) was utilised as it is
considered a potent generator of ROS. Results were recorded at
15, 30, 60, 120 and 180 min intervals and are shown in Fig. 6. The
Mn2+ complex 2 was found to be an exceptional ROS generator
with greatest activity, relative to H2O2 (+Ctrl), across the
concentration range 1000–250 nM and registering approximate
equal activity to 0.5 mM hydrogen peroxide at 125 nM. It is
worth commenting that 2 was almost seven times more active
than the next most effective ROS generator, phen. The activity of
the Cu2+ complex, (1), even when assessed across a much higher
concentration range (100,000–195 nM) was considerably lower
than that of metal-free phen and complex 2. The clinical agent,
cisplatin, was the least active of all. This is not surprising
considering that it is non-catalytic. Furthermore, it is known that
cisplatin only becomes cytotoxic upon hydrolysis to [Pt
(NH3)2(OH)2], which generally occurs 48–96 h post intravenous
administration.22582 | Med. Chem. Commun., 2011, 2, 579–584In vivo drug tolerance
Larvae of the insect Galleria mellonella (the greater wax moth)
were employed to assess the in vivo cytotoxic tolerance of
complexes 1 and 2, metal-free phen and cisplatin. Larvae of G.
mellonella have been widely used as a convenient and inexpensive
in vivo screening model to assess the therapeutic potential of
novel antimicrobial drugs.23,24 They have yielded results that are
considered comparable to those obtained using mammalian
models.25 The innate defences of insects, including G. mellonella,
like those of mammals consist of structural and passive barriers
as well as humoral and cellular responses within the haemolymph
(analogous to the blood of mammals).26 Indeed cellular
responses within the haemolymph are often activated by signal
transduction systems comparable to mice.27
Testing was carried out in triplicate using ten healthy G. mel-
lonella larvae in the 6th developmental stage. Compounds were
tested across the concentration range 5000100 mg mL1 (333–13
mg kg1 average body weight) with sterile test solutions being
administered via hypodermic injection. Larvae were incubated at
30 C for 72 h with survival being monitored at 24 h intervals and
significance being determined using the log rank (Mantel-Cox)
method. Death was assessed by the lack of movement in response
to stimulus together with discolouration. Results are presented
(Table 4) as the mean % kill ( standard deviation) resulting
from exposure to the tested compound. Larvae exposed to high
concentrations of the compounds (5000 and 2000 mg mL1)
showed poor tolerance. However, at the lower concentration
ranges (1000–200 mg mL1) significant differences were observed.
Larvae had the highest tolerance to complexes 1 and 2 (50 and
40% kill at 67 mg kg1, respectively, and 0% kill at 33 mg kg1).
Cisplatin was the least well tolerated of the test compounds, with
high toxicity (60% kill) being observed at 500 mg mL1 (33 mg
kg1). This value for cisplatin correlates well with the known
LD50 value for this drug (32.7 mg kg
1 body weight) in the mouse
model (oral exposure) but appears somewhat higher than the
reported mouse intravenous LD50 value (11 mg kg
1 body
weight).28 These differences could arise in mammals due to the
dose-limiting toxicity of cisplatin toward renal tubular damage.28Proposed DNA self-cleaving mechanism
One possible mechanism by which the Cu2+ complex, 1, self-
activates the phosphodiester backbone in DNA is via the
formation of a p carboxylate radical which concomitantly leads
to the formation of the reduced Cu+ species, [Cu(phen)2]
+
(Scheme 1). Aliphatic carboxylate radicals are known to react by
hydrogen abstraction in close competition with decarboxyl-
ation.29,30 Generation of a p carboxylate radical within complex
1 would depend on the strength of the HOMO d orbital overlap
on Cu2+ with the oxygen carboxylate. From previous X-ray
crystallographic studies it is known that the Cu–O bond length in
1 is 1.974 A and that it is significantly shorter than the equivalent
Mn–O bond in 2 (2.147 A).13,14 However, some degree of caution
must be exercised when invoking this radical theory based on
metal-oxygen (carboxylate) bond lengths since the Cu–O bond
length may alter when 1 binds to DNA.
Cu2+/ Cu+ (+0.15 eV) (III)This journal is ª The Royal Society of Chemistry 2011
Fig. 6 Generation of endogenous reactive oxygen species (ROS) within the cancer cell line HT29 after exposure to; (a) the free ligand 1,10-phenan-
throline, (b) the clinical antitumour agent cisplatin, (c) complex 1 and (d) complex 2.
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View Article OnlineMn2+/ Mn0 (1.18 eV) (IV)
Considering the standard reduction potentials for Cu2+ (III)
and Mn2+ (IV) could explain why the Cu2+ complex, 1, self-
activates SC DNA while the Mn2+ complex, 2, does not.
Carboxylate anions could not be considered potent reducing
agents and so metal ions that may show this effect are ions, like
Cu2+, that have very low oxidation potentials between theMn and
Mn1 state.
The proposed mechanism proceeds by the following steps: (i)
after the intercalation of 1 to DNA (discussed in relation to Table
1), homolytic cleavage at the Cu–O bond generates the p
carboxyl radical (---) and the reduced Cu+ d10 complex [CuTable 4 % Kill of G. mellonella larvae after exposures to 5000–100 mg mL1
cisplatin over the period 72 h†
% Kill of Galleria mellonella larve (72 h)
Concentration mg mL1 (mg kg1 bo dy weight) 
5000 (333) 2000 (133)
phen 100 ( 0) 90 ( 1)
cisplatin 100 ( 0) 100 ( 0)
1 93.30 ( 0.58) 86.70 ( 0.58)
2 93.30 ( 1.15) 93.30 ( 0.58)
This journal is ª The Royal Society of Chemistry 2011(phen)2]
+. The resultant carboxyl p radical (p-RCO2_) undergoes
rapid conversion to a s radical (s-RCO2_) which decarboxylates
to generate CO2 and R_. (ii) [Cu(phen)2]
+ reacts, as previously
reported,31with O2 to generate the superoxide radical through an
intermediate (phen)2-Cu
2+-O2_
 which then decomposes to [Cu
(phen)2]
2+ and O2_
. (iii) Either complex 1 or [Cu(phen)2]
2+
subsequently react with O2_
 to generate H2O2 (as discussed in
relation to Fig. 5 and Table 2). (iv) Since 1 does not dispropor-
tionate hydrogen peroxide a subsequent reaction of [Cu(phen)2]
+
with H2O2 in (a) or O2 in (b) can generate known metal-oxo and
hydroxyl radical bond activators ((phen)2-Cu
+/2+-O2_ and HO_).
31
Since some nuclease activity was detected for 1 in the presence of
the powerful metal chelator EDTA (Fig. 4(c)) it appears feasible
that the carboxyl radical, and/or its breakdown product (R_), isof complexes 1 and 2, the ligand phen and the clinical antitumour drug
S.D.
1000 (67) 500 (33) 200 (13)
80 ( 0) 0 ( 0) 0 ( 0)
100 ( 0) 60 ( 1) 0 ( 0)
50 ( 1) 0 ( 0) 0 ( 0)
40 ( 1) 0 ( 0) 0 ( 0)
Med. Chem. Commun., 2011, 2, 579–584 | 583
Scheme 1 Proposedmechanism of generating C–Hbond activators (---).
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View Article Onlinecapable of abstracting H$ from the phosphodiester backbone of
DNA. In the absence of oxygen, the self-cleaving nuclease
potential of 1 is diminished (Fig. 4 (c)), and since, in the proposed
mechanism, steps (ii)–(iv) are O2-dependent, it stands to reason
that the nuclease potential of this copper complex would be less
in the absence of these aerobically-generated oxo- and hydroxo-
bond activators. Efforts are currently underway in our labora-
tory to establish direct experimental evidence for this proposed
mechanism.
Conclusions
In summary, dinuclear, water-soluble [Cu2(m2-oda)(phen)4]
(ClO4)2 (1) and {[Mn2(m2-oda)(phen)4(oda)2]
2[Mn2(m2-oda)
(phen)4(H2O)2]
2+} (2), in comparison to other mononuclear
metal-phen adducts, represent a significant advancement in the
area of DNA-targeted chemotherapeutics. These Cu2+ and Mn2+
bis(phen) octanedioate complexes have powerful and unprece-
dented cytotoxicity, encouraging cytoselectivity and in vivo drug
tolerance. Both complexes are avid binders of DNA, and the
Cu2+ complex has the capacity to self-cleave DNA, possibly
through the generation of a p carboxyl radical. The Mn2+
complex is an exceptional redox catalyst that generates remark-
able levels of intracellular ROS within HT29 colorectal cancer
cells compared to hydrogen peroxide.
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